Oesophageal tumour progression between the diagnostic 18F-FDG- PET and the 18F-FDG-PET for radiotherapy treatment planning

Radiotherapy and Oncology

Volumn 106, Issue 3, 2013, Pages 283-287

  Muijs, Christina T ^a   Pruim, Jan ^a   Beukema, Jannet C ^a   Berveling, Maaike J ^a   Plukker, John Th ^a   Langendijk, Johannes A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Oesophageal cancer; PET; Tumour progression

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84876140652     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.10.015     Document Type: Article

References (27)

1. J.L. Geh, S.J. Bond, S.M. Bentzen, and R. Glynne-Jones Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response Radiother Oncol 78 2006 236 244
2. G.L. Smith, B.D. Smith, and T.A. Buchholz Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: the SEER-medicare cohort Int J Radiat Oncol Biol Phys 2009
3. V. Gebski, B. Burmeister, B.M. Smithers, K. Foo, J. Zalcberg, and J. Simes Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234
4. M.A. Eloubeidi, R. Desmond, M.R. Arguedas, C.E. Reed, and C.M. Wilcox Prognostic factors for te survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status Cancer 95 2002 1434 1443
5. E.A. Griffiths, Z. Brummell, G. Gorthi, S.A. Pritchard, and I.M. Welch Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses J Surg Oncol 93 2006 258 267
6. A. Suzuki, L. Xiao, and Y. Hayashi Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy Cancer 2011
7. L. Moureau-Zabotto, E. Touboul, and D. Lerouge Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma Int J Radiat Oncol Biol Phys 63 2005 340 345
8. S.B. Edge, D.R. Byrd, and C.C. Compton AJCC cancer staging manual 7th ed. 2009 Springer New York
9. R. Boellaard, M.J. O'Doherty, and W.A. Weber FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 Eur J Nucl Med Mol Imaging 37 2010 181 200
10. R. Boellaard, W.J. Oyen, and C.J. Hoekstra The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials Eur J Nucl Med Mol Imaging 35 2008 2320 2333
11. R. Boellaard Standards for PET image acquisition and quantitative data analysis J Nucl Med 50 Suppl. 1 2009 11S 20S [Epub 2009 Apr 20]
12. J.F. Bruzzi, S.G. Swisher, and M.T. Truong Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy Cancer 109 2007 125 134
13. R.J. Cerfolio, A.S. Bryant, B. Ohja, A.A. Bartolucci, and M.A. Eloubeidi The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy J Thorac Cardiovasc Surg 129 2005 1232 1241
14. P. Flamen, E. Van Cutsem, and A. Lerut Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer Ann Oncol 13 2002 361 368
15. R.L. Blom, W.M. Schreurs, H.J. Belgers, L.E. Oostenbrug, R.F. Vliegen, and M.N. Sosef The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma Eur J Surg Oncol 37 2011 774 778
16. W.A. Weber, K. Ott, and K. Becker Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging J Clin Oncol 19 2001 3058 3065
17. S. Yuan, Y. Yu, and K.S. Chao Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer J Nucl Med 47 2006 1255 1259
18. L.M. Schreurs, B.B. Pultrum, and K.P. Koopmans Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer Anticancer Res 28 2008 1867 1873
19. A.J. Graham, F.M. Shrive, and W.A. Ghali Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis Ann Thorac Surg 83 2007 1257 1264
20. C.T. Muijs, J.C. Beukema, J. Pruim, V.E. Mul, H. Groen, and J.T. Plukker A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer Radiother Oncol 97 2010 165 171
21. C.T. Muijs, L.M. Schreurs, and D.M. Busz Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer Radiother Oncol 93 2009 447 453
22. O. Vrieze, K. Haustermans, and W. De Wever Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Radiother Oncol 73 2004 269 275
23. W.J. Cai, and P.L. Xin Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy Radiother Oncol 96 2010 104 107
24. S. Basu, J. Kung, M. Houseni, H. Zhuang, G.F. Tidmarsh, and A. Alavi Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions Q J Nucl Med Mol Imaging 53 2009 9 19
25. Y. Hu, C. Hu, H. Zhang, Y. Ping, and L.Q. Chen How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol 17 2010 784 790
26. J.D. Luketich, P.R. Schauer, and C.C. Meltzer Role of positron emission tomography in staging esophageal cancer Ann Thorac Surg 64 1997 765 769
27. H. Kato, H. Kuwano, and M. Nakajima Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer 94 2002 921 928